Tüdőrák: vizsgálatok itt: Tajvan
144 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
- Where
- Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
- Életkor
- 18 év and over
- People
- 686 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06899126 · EU 2024-515658-26-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- Where
- Kaohsiung City, Kaohsiung Niao Sung Dist, New Taipei City, Taichung, Taoyuan
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07361510 · EU 2025-523586-18-00 - 1/2. fázisTaking peopleA Study of Dato-DXd in Participants With Solid Tumors [TROPION-PanTumor04 (TP04)]
- Where
- Taichung
- Életkor
- 18 év and over
- People
- 268
- Run by
- Daiichi Sankyo
See details and how to joinNCT07890714 · EU 2024-519729-39-00 - 2. fázisTaking peopleNeoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Where
- Liuying, New Taipei City, Tainan, Taipei
- Életkor
- 18 év to 95 év
- People
- 630 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05061550 · EU 2023-508852-21-00 - 1/2. fázisTaking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Kaohsiung City, New Taipei City, Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - 3. fázisTaking peopleStudy of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
- Where
- Changhua, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
- Életkor
- 18 év and over
- People
- 695 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06801834 - 1/2. fázisTaking peopleStudy of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Where
- Kaohsiung City, Taichung, Tainan, Taipei
- Életkor
- 18 év and over
- People
- 616 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06162221 · EU 2025-521147-21-00 - No phaseNot yet taking people in TajvanAcupuncture and Laser Acupuncture for Advanced Non-Small Cell Lung Cancer
- Where
- Taichung
- Életkor
- 18 év and over
- People
- 90
- Run by
- China Medical University, Taiwan
See details and how to joinNCT07879768 - 2. fázisTaking peopleA Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
- Where
- Changhua, Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06731907 · EU 2024-515772-12-00 - 2. fázisTaking peopleA Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
- Where
- Liuying, Taichung, Tainan, Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 278 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07098338 · EU 2025-524843-11-00 - 1. fázisTaking peopleA Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Where
- Kaohsiung City
- Életkor
- 18 év and over
- People
- 110 worldwide
- Run by
- EpiBiologics
See details and how to joinNCT07462377 - 1/2. fázisTaking peopleA Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Where
- Taichung, Tainan, Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05123482 · EU 2022-502759-70-01 - 2. fázisNot yet taking people in TajvanA Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)
- Where
- Taichung, Tainan, Taipei
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07871214 - 2. fázisTaking peopleSymbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- Where
- Tainan, Taipei
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Pfizer
See details and how to joinNCT07476287 · EU 2025-524686-24-00 - 3. fázisTaking peopleSymbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Where
- Changhua County, Hsinchu, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 1410 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222566 · EU 2025-523461-17-01 - 2/3. fázisTaking peopleSymbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
- Where
- Tainan, Taipei
- Életkor
- 18 év and over
- People
- 550 worldwide
- Run by
- Pfizer
See details and how to joinNCT07226999 · EU 2025-523522-41-00 - 1/2. fázisTaking peopleSymbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- Where
- Kaohsiung City, Tainan, Taipei
- Életkor
- 18 év and over
- People
- 162 worldwide
- Run by
- Pfizer
See details and how to joinNCT07227298 · EU 2025-523526-40-00 - 2. fázisTaking peopleSymbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Where
- Taichung, Tainan, Taipei
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Pfizer
See details and how to joinNCT07489066 · EU 2025-524825-42-00 - 1/2. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- Where
- Tainan, Taipei
- Életkor
- 18 év and over
- People
- 327 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06780137 · EU 2024-517926-25-00 - 1/2. fázisTaking peoplePhase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Where
- Taichung, Tainan, Taipei
- Életkor
- 18 év to 130 év
- People
- 622 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05797168 · EU 2022-502576-23-00 - No phaseTaking peopleCompassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC)
- Where
- Taipei
- Életkor
- 20 év and over
- People
- 84
- Run by
- Taipei Medical University
See details and how to joinNCT06930313 - 2/3. fázisTaking peopleA Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Where
- Kaohsiung City, Taipei
- Életkor
- 18 év and over
- People
- 854 worldwide
- Run by
- AbbVie
See details and how to joinNCT07005102 - 2/3. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Where
- Changhua, Kaohsiung City, Taichung, Taipei, Taoyuan City
- Életkor
- 18 év and over
- People
- 490 worldwide
- Run by
- AbbVie
See details and how to joinNCT07155187 · EU 2025-521124-29-00 - 1. fázisTaking peopleA Study of ZW251 in Participants With Advanced Solid Tumors
- Where
- Taipei
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Zymeworks BC Inc.
See details and how to joinNCT07164313 - 3. fázisTaking peopleNeladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Where
- Kaohsiung City, Taichung, Tainan, Taipei
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT06765109 · EU 2024-517553-26-00